secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2024-10-01T23:59:59+00:00
Accession:  0001193125-24-230240
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Verrica cuts 47 jobs, expects $1.0M restructuring charge
--------------------------------------------------------

- Workforce reduction of 47 employees, substantially completed by October 1, 2024.
- Total restructuring expense estimated at $1.0M: $0.7M termination costs and $0.3M vehicle sale loss.
- Charge to be recorded in Q4 2024; cash payments expected by November 30, 2024.
- Board approved September 23, 2024 to streamline operations and preserve capital.
- One-time costs are the only direct expenses of the restructuring plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312524230240/0001193125-24-230240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312524230240/d823075d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-230240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer